Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Merck
Johnson and Johnson
US Army
Julphar
Medtronic
Boehringer Ingelheim
Harvard Business School
QuintilesIMS

Generated: May 25, 2018

DrugPatentWatch Database Preview

FENOLDOPAM MESYLATE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Summary for FENOLDOPAM MESYLATE
Drug patent expirations by year for FENOLDOPAM MESYLATE
Medical Subject Heading (MeSH) Categories for FENOLDOPAM MESYLATE
Synonyms for FENOLDOPAM MESYLATE
1H-3-Benzazepine-7,8-diol, 6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-, methanesulfonate (salt)
3B1-007207
6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol; methanesulfonic acid
6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol;methanesulfonic acid
6-Chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol
6-Chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol mesylate
6-Chloro-2,3,4,5-tetrahydro-1-(p-hydroxyphenyl)-1H-3-benzazepine-7,8-diol methanesulfonate (salt)
6-Chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(p-hydroxyphenyl)-1H-3-benzazepinium methanesulphonate
6-chloro-7,8-dihydroxy-1-(p-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine methane sulfonate
67227-56-9 (Parent)
67227-57-0
87900-91-2
9-chloranyl-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol; methanesulfonic acid
9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol,methanesulfonic acid
9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol; methanesulfonic acid
A835665
AC1L2M4N
AKOS030254549
AN-38413
C16H16ClNO3.CH4O3S
C17H20ClNO6S
CCG-100942
CCG-213480
CHEBI:5003
CHEMBL1026
Corlopam (TN)
Corlopam mesylate
CPD000469190
CTK8F9745
CVKUMNRCIJMVAR-UHFFFAOYSA-N
D00613
DR002360
EINECS 266-612-7
Fenoldopam (mesylate)
Fenoldopam mesilate
Fenoldopam mesylate (USP)
Fenoldopam mesylate [USAN:USP]
Fenoldopam mesylate [USAN]
Fenoldopam mesylate, >=98% (HPLC)
Fenoldopam mesylate, United States Pharmacopeia (USP) Reference Standard
Fenoldopam methanesulfonate
Fenoldopam monomethanesulfonate
FENOLDOPAM; METHANESULFONIC ACID
Fenoldopam(mesylate)
FT-0626401
HE378072
HMS2051P09
HMS2230J03
HMS3264B10
HMS3371L12
HMS3393P09
HY-B0735A
K106
KS-00001F84
LS-27994
M27F569
MLS001401388
MolPort-003-666-835
NC00192
NSC-759860
NSC759860
Pharmakon1600-01505539
s4618
SAM001246665
SCHEMBL41213
SK-82526-J
SK&F 82526-J
SK&F-82526J
SKF 82526 (mesylate)
SKF 82526-J
SKF 82526J
SMR000469190
W-104725
Z2210694608

US Patents and Regulatory Information for FENOLDOPAM MESYLATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold FENOLDOPAM MESYLATE fenoldopam mesylate INJECTABLE;INJECTION 076656-001 Dec 1, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int FENOLDOPAM MESYLATE fenoldopam mesylate INJECTABLE;INJECTION 076582-001 Oct 12, 2004 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sandoz Inc FENOLDOPAM MESYLATE fenoldopam mesylate INJECTABLE;INJECTION 077155-001 Feb 15, 2005 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Parenteral FENOLDOPAM MESYLATE fenoldopam mesylate INJECTABLE;INJECTION 077826-001 Mar 7, 2007 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Queensland Health
US Department of Justice
Deloitte
Merck
US Army
QuintilesIMS
Cerilliant
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.